|Articles|December 31, 2016

Facebook Users Comment on Vaccines: The Top-Most Viewed Article of 2016

Author(s)Einav Keet

This year’s most-viewed article on ContagionLive combined two hot-button issues: social media and vaccination.

Contagion’s most-viewed article of 2016 detailed a study examining how Facebook users expressed pro-vaccine and anti-vaccine viewpoints.

The study focused on a photo posted by Facebook founder Mark Zuckerberg with his infant daughter at the doctor’s office, with the caption, “Doctor’s visit—time for vaccines!” Posted on January 8, 2016, the photo went on to receive more than 3.4 million Facebook reactions, 83,000 comments, and 36,000 shares. The researchers saw the large volume of Facebook user interaction with the post as an opportunity to analyze how people on both sides of the debate see the risks and benefits of vaccination.

The study was published in the journal, Vaccine, and included findings from an analysis of about 1,400 Facebook user comments on Zuckerberg’s post. The researchers approached the study aware that although the internet has become a useful tool for information gathering on health issues, it has also become an “echo chamber” where misinformation about vaccines and anti-vaccination attitudes have spread. This has led to a decrease in vaccination rates and in some cases outbreaks of diseases once largely eradicated.

In their analysis of the user comments, and to their surprise, the authors found that comments in favor of vaccination tended to express more anxiety around issues such as herd immunity, while comments against vaccination were structured more logically and included more commentary on health, biology, and scientific research. “This concerns us because the scientific evidence is very clear in demonstrating the safety and benefits of vaccines,” said study author Kate Faasse, PhD, in a press release. “Because these skeptical comments appear on the surface to be quite logical and, because they focus on health, biology, and research, they may be particularly compelling for parents who are uncertain about what decision to make about childhood vaccination and are seeking more information.”

The authors hope their findings can inform how health officials communicate and address concerns regarding vaccination, says Dr. Faase, noting that “greater insight about the specific worries people have about vaccination and decisions not to vaccinate can help us provide accurate information to better address these concerns.”

The original article, “Study Examines Facebook User Comments on Vaccines,” is available here.


Related to this article

Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
FAQ: Ebola Prevention, Treatment and the Chances of a US Outbreak
As the Bundibugyo virus outbreak in the Democratic Republic of the Congo surpasses 9300 confirmed cases and 4400 deaths, this FAQ explains how the virus spreads, how it presents, why it is hard to diagnose and treat, which vaccines and therapies are being tested, and why CDC considers the risk to the United States low.
Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.
Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.